Specialty distributors achieve high-service efficiencies, enhanced reliability and performance in 2023
The industry achieved a 99.4% order fill rate, delivering medications to provider customers in an average of 1.3 days.
The industry achieved a 99.4% order fill rate, delivering medications to provider customers in an average of 1.3 days.
Francois Mandeville named executive vice president, Strategy and M&A, and Pawan Verma was appointed executive vice president, chief data and information officer.
Real-world data delivers unique insights to help health care providers navigate changes in payor reimbursement behaviors.
Patrick Cornacchiulo, CEO of FITCRUNCH, will assume the same role at 1440.
CeraVe and Vichy Derco made their forays into new markets today. CeraVe launched its first haircare line, and Vichy Dercos brought their anti-dandruff products stateside.
According to a new report from CoBank’s Knowledge Exchange, food and beverage companies are streamlining their product portfolios by shedding brands that don’t align with their core strengths.
“This expansion into CVS, one of the largest retailers in the U.S., is truly a massive milestone for a brand not even at its one-year mark,” said cofounder Jeff Aronson.
First over-the-counter daily birth control pill now available to order via GoodRx’s new direct-to-consumer shopping experience.
Brand expanding and accelerating collaboration with dermatologists to foster innovation.
La Roche-Posay announces 2023 grant winners and calls for 2024 program applicants.
Avanafil tablets is a phosphodiesterase 5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction.
This year’s study reported 75% usage rate remains in line with last year’s data, demonstrating the ongoing role supplements play in supporting health and wellness.
2025 Pharmacy Transformation Study to explore evolving expectations for pharmacists and the multi-faceted and systemic approach needed to make it a reality to enhance patient access and equity
Applauds international commission’s rejection of duplicative and burdensome probiotics proposal.
This marks the third consecutive appearance of Dr. Reddy’s in the list.
This year’s program took place on Wednesday, Oct. 9, as one of the lead-in events to CRN’s annual conference — CONVERGENCE — at the Grand America Hotel in Salt Lake City.